We understand that covered entities are extremely cautious about disclosing any 340B Program information related to their facility, patients, and contract pharmacies. The specificity of the information Kalderos is requesting within Kalderos Review has been authorized by our pharmaceutical manufacturer clients. Please find letters authorizing Kalderos to contact covered entities on behalf of our Kalderos Review clients below:
Alkermes
AstraZeneca
Biogen
Coherus BioSciences
Daiichi Sankyo (DSI)
Gilead Sciences
Celgene / BMS*
Comments
0 comments
Article is closed for comments.